Company / Working Capital
Prime Medicine, Inc. Working Capital History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$173.9M
FY2024
5-year range
$86.6M / $269.9M
FY2021-FY2024
Trend
+100.9%
vs FY2023
Sector context
#174 of 214
Health Care
What the data says
Prime Medicine, Inc.'s working capital of $174M is lower than 81% of companies in the Health Care sector (FY2024). Declined from $270M to $174M over the past 2 years.
Based on SEC 10-K filings.
$174M in FY2024 with a 3-year CAGR of -6.5%.
Declined from $270M to $174M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 214This company $173.9M Sector average $955.5M
▼
-81.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -6.5%, indicating a declining trend.
- In FY2024, working capital increased 100.9% year-over-year.
- Ranks #174 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $173.9M | +100.9% |
| FY2023 | $86.6M | -67.9% |
| FY2022 | $269.9M | +27.0% |
| FY2021 | $212.6M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026